Adalimumab Safety in Inflammatory Bowel Disease: A Clinical Cohort Study with Time-to-Event Analysis and FAERS Signal Assessment
Study Overview The investigation into the safety profile of Adalimumab, a widely used biologic medication for inflammatory bowel disease (IBD), […]
